These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Aggravation of arrhythmia: a complication of antiarrhythmic drugs. Podrid PJ J Cardiovasc Electrophysiol; 1993 Jun; 4(3):311-9. PubMed ID: 8269302 [TBL] [Abstract][Full Text] [Related]
9. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing. Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198 [TBL] [Abstract][Full Text] [Related]
10. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia. Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319 [TBL] [Abstract][Full Text] [Related]
11. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents]. Kuck KH Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932 [TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation. Stanton MS; Prystowsky EN; Fineberg NS; Miles WM; Zipes DP; Heger JJ J Am Coll Cardiol; 1989 Jul; 14(1):209-15; discussion 216-7. PubMed ID: 2738263 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents. Kudenchuk PJ; Kron J; Walance C; McAnulty JH Am J Cardiol; 1990 Feb; 65(7):446-52. PubMed ID: 2305683 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive evaluation of indecainide for serious ventricular tachyarrhythmia. Podrid PJ; Hohnloser S; Lown B Am J Cardiol; 1988 Apr; 61(10):764-9. PubMed ID: 2451415 [TBL] [Abstract][Full Text] [Related]
16. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio. Pratt CM; Eaton T; Francis M; Woolbert S; Mahmarian J; Roberts R; Young JB Am Heart J; 1989 Sep; 118(3):433-40. PubMed ID: 2476016 [TBL] [Abstract][Full Text] [Related]
17. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. Myerburg RJ; Kessler KM; Cox MM; Huikuri H; Terracall E; Interian A; Fernandez P; Castellanos A Circulation; 1989 Dec; 80(6):1571-9. PubMed ID: 2480856 [TBL] [Abstract][Full Text] [Related]